← Leaderboards
James J Hickman
University Of Central Florida
$23,427,171
Attributed
$40,825,173
Total exposure
16
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,825,173 · 16
By mechanism
R44$21,754,291 · 6
R01$9,992,311 · 3
UH2$2,880,095 · 1
UH3$2,381,424 · 1
UG3$1,697,849 · 1
R43$1,119,203 · 3
Top collaborators
- Michael L Shuler32 shared
- David Morgan6 shared
- Jacques Turgeon4 shared
- Christopher Mcaleer2 shared
- James F Kronauge1 shared
Most similar at University Of Central Florida
Same institution · by research overlap
- Xiufang Guo$1,168,121
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroBaseChronicNeuronsEvaluationResponseAlzheimer&AposPharmaceutical PreparationsOrganMicroelectrodesLiverGrantSerumMeasurementLegal PatentAcuteBody SystemClinical TrialsToxic EffectPre-ClinicalBiological ModelsCantileverIn Vitro Model
Grant awards (58)
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia$1,500,000
R44 · FY2025 · AG · contact PI
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$728,632
R01 · FY2025 · AG · contact PI
Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency$1,000,000
U44 · FY2024 · TR
HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform$854,765
R44 · FY2023 · HL
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$743,502
R01 · FY2023 · AG · contact PI
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2022 · AG
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia$902,299
R44 · FY2022 · AG · contact PI
HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform$854,765
R44 · FY2022 · HL
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$764,558
R01 · FY2022 · AG · contact PI
Hesperos Diversity Supplement forgrant number 1 R44AG071386$162,742
R44 · FY2022 · AG · contact PI
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity$2,381,424
UH3 · FY2021 · TR · contact PI
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2021 · AG
Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia$902,320
R44 · FY2021 · AG · contact PI
Populating MPS database with data from multi-organ, human-on-a-chip microphysiological systems$77,997
R44 · FY2021 · TR
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,753
R44 · FY2020 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$1,483,966
R44 · FY2020 · AG
Automation and validation of human on a chip systems for drug discovery$1,404,459
R44 · FY2020 · TR
Development of an integrated 4-organ animal model$744,745
R44 · FY2020 · ES
An In Vitro Model of Stem Cell Innervation of Myotubes$481,578
R01 · FY2020 · NS · contact PI
Drug-drug interactions for antivirals with opioids and Narcan in a 5- organ human-on-a-chip model$167,033
UG3 · FY2020 · TR · contact PI
Automation and validation of human on a chip systems for drug discovery$73,535
R44 · FY2020 · TR
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity$1,530,816
UG3 · FY2019 · TR · contact PI
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,755
R44 · FY2019 · AG
Automation and validation of human on a chip systems for drug discovery$1,412,888
R44 · FY2019 · TR
Development of an integrated 4-organ animal model$744,745
R44 · FY2019 · ES
An In Vitro Model of Stem Cell Innervation of Myotubes$481,578
R01 · FY2019 · NS · contact PI
Human on a chip system to investigate genetic risk factors in Alzheimer's disease$335,252
R43 · FY2019 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$224,999
R44 · FY2019 · AG
Automation and validation of human on a chip systems for drug discovery$186,828
R44 · FY2019 · TR
Automation and validation of human on a chip systems for drug discovery$1,363,424
R44 · FY2018 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$481,578
R01 · FY2018 · NS · contact PI
Human on a chip system to investigate genetic risk factors in Alzheimer's disease$334,005
R43 · FY2018 · AG
Human on a chip systems to investigate disease comorbidities common in the aged population$224,999
R44 · FY2018 · AG
HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform$224,946
R43 · FY2018 · HL
Development of an integrated 4-organ animal model$220,124
R44 · FY2018 · ES
Advanced Human on a Chip Systems for Drug Discovery$735,615
R44 · FY2017 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$481,578
R01 · FY2017 · NS · contact PI
Functional integrated human-on-a-chip systems for Alzheimer's research$454,315
R44 · FY2017 · AG
Integration of a kidney module into a 4-organ human-on-a-chip system.$225,000
R43 · FY2017 · DK
Advanced Human on a Chip Systems for Drug Discovery$1,241,321
R44 · FY2016 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$481,578
R01 · FY2016 · NS · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$403,428
R01 · FY2015 · NS · contact PI
Microphysiologial systems and low cost microfluidic platform with analytics$549,095
UH2 · FY2014 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$398,732
R01 · FY2014 · NS · contact PI
Microphysiologial systems and low cost microfluidic platform with analytics$1,054,728
UH2 · FY2013 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$388,051
R01 · FY2013 · NS · contact PI
Microphysiologial systems and low cost microfluidic platform with analytics$151,272
UH2 · FY2013 · TR
Microphysiologial systems and low cost microfluidic platform with analytics$1,125,000
UH2 · FY2012 · TR
An In Vitro Model of Stem Cell Innervation of Myotubes$401,518
R01 · FY2012 · NS · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$400,932
R01 · FY2011 · NS · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$403,008
R01 · FY2009 · NS · contact PI
High-throughput Electrophysiology for Pathway Identification$462,135
R01 · FY2008 · EB · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$397,945
R01 · FY2008 · NS · contact PI
High-throughput Electrophysiology for Pathway Identification$429,661
R01 · FY2007 · EB · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$418,401
R01 · FY2007 · NS · contact PI
High-throughput Electrophysiology for Pathway Identification$429,994
R01 · FY2006 · EB · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$427,233
R01 · FY2006 · NS · contact PI
An In Vitro Model of Stem Cell Innervation of Myotubes$386,691
R01 · FY2005 · NS